U.S. MarketsOctober 19 at 08:02 AM

Johnson & Johnson (JNJ) to release 48‑week Tremfya data in Crohn’s disease

StockNow breaking-news AI analysis

The headline reports a planned 48-week Tremfya data release in Crohn’s disease; the supplied record contains no supporting article text or study details.

1 stocks

JNJJohnson & Johnson$253.85Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Geopolitics

"A breakthrough is expected to be announced this week to halt the escalation between Washington and Tehran", Al Araby Al Jadeed reports citing a source

FX/Bonds

[MARKET UPDATE] Bout of USD strength weighs on G10 peers, with EUR/USD falling beneath 1.1200, to a recent low of 1.1187; no clear driver

U.S. Markets

SpaceX's (SPCX) Musk says "I will give one of my SpaceX shares to every kid in America next year"

SPCX